Changes in bone mineral density after initiation of antiretroviral treatment with Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
Todd T. Brown*, Carlee Moser, Judith S. Currier, Heather J. Ribaudo, Jennifer Rothenberg, Theodoros Kelesidis, Otto Yang, Michael P. Dubé, Robert L. Murphy, James H. Stein, Grace A. Mccomsey
Dive into the research topics of 'Changes in bone mineral density after initiation of antiretroviral treatment with Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir'. Together they form a unique fingerprint.